lorazepam has been researched along with buspirone in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (29.17) | 18.7374 |
| 1990's | 13 (54.17) | 18.2507 |
| 2000's | 2 (8.33) | 29.6817 |
| 2010's | 2 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hill, JL; Lawlor, BA; Minichiello, M; Molchan, SE; Radcliffe, JL; Sunderland, T | 1 |
| Kaplan, HL; Romach, MK; Schneiderman, JF; Sellers, EM; Somer, GR | 1 |
| Alford, C; Bhatti, JZ; Curran, S; Hindmarch, I; McKay, G | 1 |
| Critchfield, TS; Griffiths, R | 1 |
| Hales, RE; Silver, JM; Yudofsky, SC | 1 |
| Morse, WH; Teeple, ES; Wettstein, JG | 2 |
| Cassano, GB; Guerani, G; McNair, D; Melis, G; Nisita, C; Petracca, A | 1 |
| Davidson, TL | 1 |
| Peroutka, SJ | 1 |
| Alderdice, MT; Marunycz, JD; Napoliello, MJ; Newton, RE | 1 |
| Ator, NA; Griffiths, RR | 1 |
| Cohn, JB; Wilcox, CS | 1 |
| Jerkovich, GS; Preskorn, SH | 1 |
| Aranko, K; Mattila, MJ; Seppälä, T; Shrotriya, RC | 1 |
| Aranko, K; Mattila, MJ; Seppala, T | 1 |
| Casacchia, M; Delle Chiaie, R; Kotzalidis, GD; Pancheri, P; Stratta, P; Zibellini, M | 1 |
| Ator, NA; Griffiths, RR; Sannerud, CA | 1 |
| Bourin, M; Malinge, M | 1 |
| Baghai, T; Ehrentraut, S; Kuhn, K; Laakmann, G; Lorkowski, G; Schüle, C | 1 |
4 review(s) available for lorazepam and buspirone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacologic management of aggression in the elderly.
Topics: Aged; Aggression; Antipsychotic Agents; Benzodiazepines; Buspirone; Dementia; Haloperidol; Humans; Lorazepam; Neurocognitive Disorders | 1990 |
Treatment of generalized anxiety disorder: preliminary clinical experience with buspirone.
Topics: Ambulatory Care; Anxiety Disorders; Buspirone; Double-Blind Method; Female; Humans; Lorazepam; Male; Middle Aged; Psychiatric Status Rating Scales | 1990 |
Review of the side-effect profile of buspirone.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as Topic; Clorazepate Dipotassium; Diazepam; Dizziness; Double-Blind Method; Drug Evaluation; Fatigue; Headache; Humans; Lorazepam; Pyrimidines | 1986 |
10 trial(s) available for lorazepam and buspirone
| Article | Year |
|---|---|
A single oral dose challenge of buspirone does not affect memory processes in older volunteers.
Topics: Administration, Oral; Aged; Aged, 80 and over; Buspirone; Double-Blind Method; Female; Humans; Lorazepam; Male; Mental Recall; Middle Aged; Neuropsychological Tests | 1992 |
Comparative drug effects and abuse liability of lorazepam, buspirone, and secobarbital in nondependent subjects.
Topics: Adult; Affect; Attention; Buspirone; Dose-Response Relationship, Drug; Humans; Lorazepam; Male; Mental Recall; Neuropsychological Tests; Personality Inventory; Psychomotor Performance; Secobarbital; Substance-Related Disorders | 1992 |
Pharmacodynamic effects of buspirone and clobazam.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Buspirone; Clobazam; Dose-Response Relationship, Drug; Female; Flicker Fusion; Humans; Lorazepam; Memory; Middle Aged; Psychomotor Performance; Random Allocation | 1991 |
Treatment of generalized anxiety disorder: preliminary clinical experience with buspirone.
Topics: Ambulatory Care; Anxiety Disorders; Buspirone; Double-Blind Method; Female; Humans; Lorazepam; Male; Middle Aged; Psychiatric Status Rating Scales | 1990 |
Review of the side-effect profile of buspirone.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as Topic; Clorazepate Dipotassium; Diazepam; Dizziness; Double-Blind Method; Drug Evaluation; Fatigue; Headache; Humans; Lorazepam; Pyrimidines | 1986 |
Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study.
Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as Topic; Double-Blind Method; Fatigue; Female; Humans; Lorazepam; Male; Middle Aged; Pyrimidines; Sleep Stages | 1986 |
Acute effects of buspirone and alcohol on psychomotor skills.
Topics: Adult; Anti-Anxiety Agents; Buspirone; Double-Blind Method; Drug Interactions; Ethanol; Humans; Lorazepam; Male; Motor Skills; Psychomotor Performance; Pyrimidines | 1982 |
Assessment of the efficacy of buspirone in patients affected by generalized anxiety disorder, shifting to buspirone from prior treatment with lorazepam: a placebo-controlled, double-blind study.
Topics: Adult; Anxiety Disorders; Buspirone; Double-Blind Method; Female; Humans; Lorazepam; Male; Middle Aged; Psychiatric Status Rating Scales; Time Factors | 1995 |
Controlled comparison of the effects and abrupt discontinuation of buspirone and lorazepam.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Double-Blind Method; Female; Humans; Lorazepam; Male; Middle Aged; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome | 1995 |
Buspirone and lorazepam in the treatment of generalized anxiety disorder in outpatients.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Double-Blind Method; Female; Humans; Lorazepam; Male; Manifest Anxiety Scale; Middle Aged; Serotonin Receptor Agonists; Time Factors; Treatment Outcome | 1998 |
12 other study(ies) available for lorazepam and buspirone
| Article | Year |
|---|---|
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Behavioral and subjective effects of buspirone and lorazepam in sedative abusers: supra-therapeutic doses.
Topics: Adult; Behavior; Buspirone; Double-Blind Method; Humans; Hypnotics and Sedatives; Lorazepam; Male; Psychomotor Performance; Substance-Related Disorders | 1990 |
Respiratory effects of benzodiazepine-related drugs in awake rhesus monkeys.
Topics: Administration, Inhalation; Alprazolam; Animals; Anti-Anxiety Agents; Appetite Depressants; Benzodiazepines; Buspirone; Carbolines; Carbon Dioxide; Drug Therapy, Combination; Female; Flumazenil; Lorazepam; Macaca mulatta; Male; Pentobarbital; Plethysmography; Pyrazoles; Respiration | 1990 |
The long-term effects of diazepam, lorazepam, and buspirone on behavioral suppression by a shock signal.
Topics: Animals; Appetite; Buspirone; Conditioning, Classical; Diazepam; Electroshock; Lorazepam; Male; Rats; Rats, Inbred Strains; Reference Values; Reinforcement, Psychology | 1990 |
Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Binding, Competitive; Brain; Buspirone; Cattle; Depression, Chemical; Diazepam; Flunitrazepam; In Vitro Techniques; Lorazepam; Pyrimidines; Receptors, Serotonin; Tetrahydronaphthalenes | 1985 |
Discriminative stimulus effects of atypical anxiolytics in baboons and rats.
Topics: Animals; Anti-Anxiety Agents; Azabicyclo Compounds; Benzodiazepinones; Buspirone; Discrimination Learning; Flumazenil; Isoxazoles; Lorazepam; Male; Papio; Piperazines; Pyrazoles; Pyridazines; Pyrimidines; Quinolines; Rats; Rats, Inbred Strains; Receptors, GABA-A | 1986 |
Failure of buspirone to protect against lorazepam withdrawal symptoms.
Topics: Aged; Anti-Anxiety Agents; Buspirone; Humans; Lorazepam; Male; Pyrimidines; Substance Withdrawal Syndrome | 1987 |
Effects of alcohol on buspirone and lorazepam actions.
Topics: Adult; Analysis of Variance; Anti-Anxiety Agents; Buspirone; Double-Blind Method; Drug Interactions; Ethanol; Humans; Lorazepam; Male; Mental Processes; Motor Skills; Pyrimidines | 1982 |
Combination of buspirone and other drugs with beta-CCE in monkeys: effects on respiration and behavior.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Buspirone; Carbolines; Carbon Dioxide; Conditioning, Operant; Drug Interactions; Female; Flumazenil; Lorazepam; Macaca mulatta; Male; Pyridazines; Respiration; Respiratory Mechanics; Tidal Volume | 1993 |
Behavioral pharmacology of tandospirone in baboons: chronic administration and withdrawal, self-injection and drug discrimination.
Topics: Animals; Anti-Anxiety Agents; Arousal; Buspirone; Cocaine; Discrimination Learning; Dose-Response Relationship, Drug; Eating; Flumazenil; Isoindoles; Lorazepam; Male; Motor Skills; Neurologic Examination; Papio; Pentobarbital; Piperazines; Pyrimidines; Reinforcement Schedule; Self Administration; Serotonin Receptor Agonists; Substance Withdrawal Syndrome; Substance-Related Disorders | 1993 |